GTG Capital Partners
VC Fund
San Francisco, United States
GTG Capital Partners is a private equity fund that makes $10-100 million active investments in select, under-appreciated middle-market technology companies that it believes can be pivoted into technological and market disruptions for high growth. GTG actively works with their companies to engineer this hypergrowth by deploying proven bestpractices and proprietary management techniques.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries GTG Capital Partners invests in
Stages GTG Capital Partners invests in
Countries GTG Capital Partners invests in
Investment Focus
Industry
- Medical 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Wellmarker Bio
|
Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center.Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developingnew drugs that overcome resistance of existing therapeutic approaches.Additionally they are focusing on developing first-in-class biomarker-based drugs for medical unmet needs in various cancers such as colon cancer, lung cancer and liver cancer. | $11.8M / Series C / Oct 14, 2021 |
Co-Investors
Cytogen
1 deal together
eBEST
1 deal together
Elohim Partners
1 deal together
Jin & Investment Partners
1 deal together
Lead Compass Investment
1 deal together
Magellan Technology Investment
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does GTG Capital Partners invest in?
GTG Capital Partners invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did GTG Capital Partners last invest?
The most recent investment recorded for GTG Capital Partners closed in Oct 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
